Sridhar Ramaswamy, MD, awarded a Research Innovation Grant to fund his lab’s work on the mechanisms of cancer cell survival, metastasis, drug resistance, and dormancy.
Stand Up To Cancer
Stand Up To Cancer (SU2C) announced today the second round of awards for its Innovative Research Grants Program (IRG), and named the 13 young scientists that will receive a combined total of $9.74 million over the grants’ three-year term to conduct high-risk/high-reward translational cancer research. Among these is Massachusetts General Hospital Cancer Center physician-scientist, Sridhar Ramaswamy, MD, for his work with dormant cancer cells.
The grants were announced during an event at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011. These grants serve to provide much needed financial support to the next generation of research leaders, and continue SU2C’s overarching commitment to cutting-edge translational research.
Watch Sridhar Ramaswamy, MD, explain his work: